Impact of Oral Dyglomera™ on Body Fat and Blood Lipids of Overweight and Obese Adults
Condition(s):Body Fat DisorderLast Updated:August 2, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Body Fat DisorderLast Updated:August 2, 2022Completed
Condition(s):Brown Adipose Tissue; Body CompositionLast Updated:December 7, 2021Completed
Condition(s):Overweight; ObesityLast Updated:March 27, 2024Not yet recruiting
Condition(s):Body FatLast Updated:December 2, 2019Unknown status
Condition(s):Breast Asymmetry; Fat AtrophyLast Updated:April 8, 2022Not yet recruiting
Condition(s):Pedal Fat Pad AtrophyLast Updated:December 6, 2019Completed
Condition(s):Pedal Fat Pad AtrophyLast Updated:February 14, 2018Completed
Condition(s):Dumping SyndromeLast Updated:November 15, 2022Recruiting
Condition(s):AdiposityLast Updated:April 26, 2021Completed
Condition(s):Fat; Liver; NAFLDLast Updated:March 27, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.